HR8538-118

Introduced

To establish an interagency committee to coordinate activities of the Federal Government relating to biotechnology oversight, and for other purposes.

118th Congress Introduced May 23, 2024

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To establish an interagency committee to coordinate activities of the Federal Government relating to biotechnology oversight, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Healthcare, Environment.

Who Benefits and How

federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section HAF0C23D9EA804B17AE02FE7F4C2CBD64: 1. Short title This Act may be cited as the Biotechnology Oversight Coordination Act of 2024.
  • Section HAFE0A35F0D204E708E546C6C75CEF195: 2. Findings; purpose Congress finds that— biotechnology harnesses the power of biology to create new products and provides opportunities to grow the United...
  • Section H3C41DE484E3148639E4DC531859F9A68: 3. Biotechnology Oversight Coordination Committee The President, acting through the Director of the Office of Science and Technology Policy and the Director of...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To establish an interagency committee to coordinate activities of the Federal Government relating to biotechnology oversight, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.

Key Policy Areas

Government Operations, Healthcare, Environment

Primary Purpose

This bill, To establish an interagency committee to coordinate activities of the Federal Government relating to biotechnology oversight, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.

Policy Domains

Government Operations Healthcare Environment

Whole bill

Identified Gains
  • federal agencies and legislative administrators
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal agencies and legislative administrators: ,
Identified Costs
  • federal implementing agencies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,

Legislative Progress

Introduced
Introduced Committee Passed
May 23, 2024

Mr. Khanna (for himself and Mrs. Bice) introduced the following …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Government Operations Healthcare Environment
Actor Mappings
"administrator_of_epa"
→ Administrator of the Environmental Protection Agency
"secretary_of_agriculture"
→ Secretary of Agriculture
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology